시장보고서
상품코드
1429919

세계의 정밀의료 시장 보고서(2024년)

Precision Medicine Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 200 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

정밀의료 시장 규모는 향후 몇 년 동안 큰 폭으로 성장할 것으로 예상됩니다. 2028년에는 9.9%의 연평균 복합 성장률(CAGR)로 1,180억 8,000만 달러 규모로 성장할 것으로 예상됩니다. 예측 기간 동안 예상되는 확대는 노인 인구 증가, 암 발병률 증가, 신흥국의 큰 잠재력, 새로운 병원균의 출현, R&D 지출 증가, 의료비 지출 증가에 기인하는 것으로 보입니다. 예측 기간 동안 예상되는 두드러진 동향으로는 경쟁력 강화를 위한 인공지능 기술 도입, 면역 매개 질환 진단 및 맞춤형 치료 제공, 연구 개발 활동에 대한 투자 증가, 기술 및 의료 기관과의 협력 및 파트너십 구축 등이 있습니다. 제품 포트폴리오를 강화합니다.

정밀의료 시장은 암 발병률 증가로 인해 성장할 것으로 예상됩니다. 암은 여전히 전 세계 주요 사망 원인으로, 5명 중 1명이 일생 중 한 번은 암에 걸릴 것으로 예상됩니다. 암 정밀의료는 암을 유발하는 돌연변이 및 유전자 이상을 확인하기 위해 종양 DNA를 검사하는 것을 포함합니다. 이를 통해 의사는 확인된 DNA 변화를 구체적으로 표적으로 하는 개별화된 치료법을 선택할 수 있습니다. 2022년 4월 미국암협회는 미국 내 신규 암 발병 건수가 192만 건으로 집계됐다고 발표했습니다. 이는 2021년 189만 건에서 증가한 수치로, 암 유병률의 증가가 정밀의료 시장의 확장을 주도하고 있음을 강조하고 있습니다.

정밀의료 시장의 성장은 헬스케어에 대한 지출 증가로 인해 더욱 촉진되고 있습니다. 의료 지출에는 의료기기, 병원 서비스, 의사 서비스, 처방약, 공중 보건 활동과 같은 의료 제품 및 서비스에 대한 총 재정적 투자가 포함됩니다. 이러한 재정적 노력은 정밀 의료의 개발, 도입 및 주류 의료에의 통합을 촉진하는 데 매우 중요합니다. 예를 들어, 2023년 5월 영국 통계청은 영국의 의료비 지출이 명목상 9.4%, 실질 9.7% 증가했다고 보고했습니다. 2021년 총 의료비는 3,672억 5,000만 달러(2,807억 파운드)에 달했으며, 이 중 의약품 지출은 518억 4,000만 달러(396억 파운드)에 달해 의료비 증가가 정밀의료 시장의 주요 원동력이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

  • 고인플레이션이 시장에 미치는 영향
  • 우크라이나·러시아 전쟁이 시장에 미치는 영향
  • COVID-19에 의한 시장에 대한 영향

제5장 세계 시장 규모와 성장

  • 세계의 시장 성장 촉진요인과 억제요인
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계의 시장 규모 실적과 성장, 2018-2023년
  • 세계의 시장 규모 예측과 성장, 2023-2028년, 2033년

제6장 시장 세분화

  • 세계의 정밀의료 시장, 기술별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 빅데이터 분석
  • 바이오인포매틱스
  • 유전자 배열 결정
  • Drug Discovery
  • 동반진단
  • 기타 기술
  • 세계의 정밀의료 시장, 용도별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 종양학
  • 호흡기질환
  • 중추신경계 질환
  • 면역학
  • 유전병
  • 기타 용도
  • 세계의 정밀의료 시장, 최종 용도별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 제약회사
  • 진단 회사
  • 헬스케어 및 IT 기업
  • 기타 최종 용도

제7장 지역 및 국가 분석

  • 세계의 정밀의료 시장, 지역별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 세계의 정밀의료 시장, 국가별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 상황과 기업 개요

  • 정밀의료 시장 경쟁 상황
  • 정밀의료 시장 기업 개요
    • Quest Diagnostics
    • Thermo Fisher Scientific Inc.
    • Roche Holding AG
    • Medtronic plc
    • Novartis AG

제31장 기타 주요 및 혁신적인 기업

  • Pfizer Inc.
  • Qiagen
  • AstraZeneca plc.
  • Abbott Laboratories
  • Nordic Bioscience A/S
  • Takeda Pharmaceutical Company Ltd.
  • Otsuka Pharmaceutical Co. Ltd.
  • Daiichi Sankyo
  • China National Pharmaceutical Group Co., Ltd.
  • GE Healthcare
  • Randox Laboratories
  • Almac Group
  • Sun Pharma
  • Nichi-Iko Pharmaceutical Co., Ltd.
  • Daewoong Pharmaceutical Co.,Ltd

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 인수합병

제35장 향후 전망과 가능성 분석

제36장 부록

ksm 24.03.28

Precision medicine refers to a form of medical treatment that involves the prevention, detection, or treatment of diseases based on an individual's genetic or protein-related information. In order to identify the most effective treatment for an individual, precision medicine takes into account factors such as their genetics, environment, and lifestyle.

The primary technologies associated with precision medicine include bioinformatics, big data analytics, drug discovery, gene sequencing, companion diagnostics, and others. Bioinformatics technologies utilize computational tools to organize, analyze, understand, visualize, and store information related to biological macromolecules. Precision medicine is applied in various medical fields, including oncology, respiratory diseases, central nervous disorders, immunology, and genetic diseases. It is implemented across different sectors, including pharmaceuticals, diagnostic companies, healthcare, and IT firms.

The precision medicine market research report is one of a series of new reports from The Business Research Company that provides precision medicine market statistics, including precision medicine industry global market size, regional shares, competitors with a precision medicine market share, detailed precision medicine market segments, market trends and opportunities, and any further data you may need to thrive in the precision medicine industry. This precision medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The precision medicine market size has grown rapidly in recent years. It will grow from $73.11 billion in 2023 to $81.06 billion in 2024 at a compound annual growth rate (CAGR) of 10.9%. The rise observed in the historical period can be ascribed to a higher incidence of cancer, an escalating prevalence of mental health disorders, a heightened occurrence of respiratory diseases, augmented funding, a growing geriatric population, an upsurge in pharmaceutical research and development expenditure, and an expansion in healthcare expenditure.

The precision medicine market size is expected to see strong growth in the next few years. It will grow to $118.08 billion in 2028 at a compound annual growth rate (CAGR) of 9.9%. The expansion anticipated in the forecast period can be credited to the rising geriatric population, a growing prevalence of cancer, the substantial potential of emerging economies, the emergence of new pathogenic infestations, escalating research and development spending, and an increase in healthcare expenditure. Prominent trends expected in the forecast period encompass the adoption of artificial intelligence technologies to enhance competitiveness, providing diagnosis and personalized treatment for immune-mediated diseases, increased investment in research and development activities, and the establishment of collaborations and partnerships with technology and healthcare entities to enhance product portfolios.

The precision medicine market is anticipated to experience growth due to the increasing prevalence of cancer. Cancer remains a major global cause of death, with one in five individuals expected to develop the disease at some point in their lives. Precision medicine in cancer involves the examination of tumor DNA to identify mutations or genetic abnormalities contributing to cancer. This enables physicians to select personalized treatments that specifically target the identified DNA alterations. In April 2022, the American Cancer Society reported 1.92 million new cancer cases in the US, reflecting a rise from 1.89 million cases in 2021, underscoring the escalating prevalence of cancer and driving the precision medicine market's expansion.

The growth of the precision medicine market is further driven by the increasing expenditure on healthcare. Healthcare expenditure encompasses the total financial investment in healthcare goods and services, including medical equipment, hospital services, physician services, prescription drugs, and public health activities. This financial commitment is crucial for advancing the development, adoption, and integration of precision medicine into mainstream healthcare. For example, in May 2023, the Office for National Statistics reported a 9.4% increase in nominal and a 9.7% increase in real terms in healthcare spending in the UK. With the total healthcare expenditure reaching $367.25 billion (£280.7 billion) in 2021, including pharmaceutical expenditure of $51.84 billion (£39.6 billion), the rising healthcare expenditure is a key driver for the precision medicine market.

Partnerships and acquisitions among precision medicine companies are on the rise, enabling them to broaden their scope in both oncology and non-oncology domains. Continuous research and development in precision medicine are driving innovation and expanding treatment options for chronic diseases. An example is Foundation Medicine Inc.'s partnership with Epic in August 2021, aiming to integrate comprehensive genomic profiling and testing devices with Epic's electronic medical record. This collaboration streamlines access to genomic insights for oncologists and extends the reach of precision medicine to a larger population.

Ongoing research and development in precision medicine are facilitating the adoption of novel approaches and the expansion of treatment strategies for chronic diseases. Harvard Medical School and Clalit Research Institute, in a joint precision medicine research initiative launched in August 2021, are focused on translating data insights into frontline clinical interventions. This initiative includes the establishment of the first precision medicine clinic dedicated to identifying tailored therapies for patients unresponsive to standard treatments.

In April 2021, Servier Laboratories, a France-based pharmaceutical company, acquired Agios Pharmaceuticals Inc.'s commercial, clinical, and research-stage oncology portfolio for an undisclosed amount. This strategic acquisition strengthens Servier Laboratories' presence in the malignant technology market, offering potential long-term growth in the solid tumor space. The transaction encompasses marketed oncology precision medicine in malignant technology and a clinical oncology pipeline featuring multiple early-stage and phase-3 assets. Agios Pharmaceuticals, a US-based company, specializes in developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism through the growth factor pathway.

Major companies operating in the precision medicine market report are Quest Diagnostics, Thermo Fisher Scientific Inc., Roche Holding AG, Medtronic PLC, Novartis AG, Pfizer Inc., Qiagen, AstraZeneca plc., Abbott Laboratories, Nordic Bioscience A/S, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo, China National Pharmaceutical Group Co., Ltd., GE Healthcare, Randox Laboratories, Almac Group, Sun Pharma, Nichi-Iko Pharmaceutical Co., Ltd., Daewoong Pharmaceutical Co.,Ltd., GlaxoSmithKline, Teva UK Limited, Vectura Group, Merck & Co., Boehringer Ingelheim, Mylan, Zentiva, Sanofi, Apotex, Gilead Sciences, Bayer, AbbVie Inc., Amgen, Janssen Pharmaceutica, Accord Healthcare Inc., Acerus Precision Medicine Corporation, AA Pharma Inc., Sanfer, LABORATORIOS SENOSIAIN SA DE CV, Siegfried Rhein, Biocrates LifeSciences, Nanostring Technologies, Tepnel Pharma Services, Intomics, Silicon Biosystems, EMS Pharma, Hypermarcas, Eurofarma, Teuto Brasileiro, Biolab Farmaceutica, Cristalia, Uniao Quimica

North America was the largest region in the precision medicine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the precision medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The precision medicine market consists of sales of imatinib, personalized medicine, and individualized medicine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Precision Medicine Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on precision medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for precision medicine? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The precision medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Technology: Big Data Analytics; Bioinformatics; Gene Sequencing; Drug Discovery; Companion Diagnostics; Other Technology
  • 2) By Application: Oncology; Respiratory Diseases; Central Nervous System Disorders; Immunology; Genetic Diseases; Other Applications.
  • 3) By End-Use: Pharmaceutical Companies; Diagnostic Companies; Healthcare And IT Firms; Others
  • Companies Mentioned: Quest Diagnostics; Thermo Fisher Scientific Inc.; Roche Holding AG; Medtronic plc; Novartis AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Precision Medicine Market Characteristics

3. Precision Medicine Market Trends And Strategies

4. Precision Medicine Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Precision Medicine Market Size and Growth

  • 5.1. Global Precision Medicine Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Precision Medicine Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Precision Medicine Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Precision Medicine Market Segmentation

  • 6.1. Global Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Big Data Analytics
  • Bioinformatics
  • Gene Sequencing
  • Drug Discovery
  • Companion Diagnostics
  • Other Technology
  • 6.2. Global Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Respiratory Diseases
  • Central Nervous System Disorders
  • Immunology
  • Genetic Diseases
  • Other Applications
  • 6.3. Global Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical Companies
  • Diagnostic Companies
  • Healthcare And IT Firms
  • Other End-Uses

7. Precision Medicine Market Regional And Country Analysis

  • 7.1. Global Precision Medicine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Precision Medicine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Precision Medicine Market

  • 8.1. Asia-Pacific Precision Medicine Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Precision Medicine Market

  • 9.1. China Precision Medicine Market Overview
  • 9.2. China Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Precision Medicine Market

  • 10.1. India Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Precision Medicine Market

  • 11.1. Japan Precision Medicine Market Overview
  • 11.2. Japan Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Precision Medicine Market

  • 12.1. Australia Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Precision Medicine Market

  • 13.1. Indonesia Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Precision Medicine Market

  • 14.1. South Korea Precision Medicine Market Overview
  • 14.2. South Korea Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Precision Medicine Market

  • 15.1. Western Europe Precision Medicine Market Overview
  • 15.2. Western Europe Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Precision Medicine Market

  • 16.1. UK Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Precision Medicine Market

  • 17.1. Germany Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Precision Medicine Market

  • 18.1. France Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Precision Medicine Market

  • 19.1. Italy Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Precision Medicine Market

  • 20.1. Spain Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Precision Medicine Market

  • 21.1. Eastern Europe Precision Medicine Market Overview
  • 21.2. Eastern Europe Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Precision Medicine Market

  • 22.1. Russia Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Precision Medicine Market

  • 23.1. North America Precision Medicine Market Overview
  • 23.2. North America Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Precision Medicine Market

  • 24.1. USA Precision Medicine Market Overview
  • 24.2. USA Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Precision Medicine Market

  • 25.1. Canada Precision Medicine Market Overview
  • 25.2. Canada Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Precision Medicine Market

  • 26.1. South America Precision Medicine Market Overview
  • 26.2. South America Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Precision Medicine Market

  • 27.1. Brazil Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Precision Medicine Market

  • 28.1. Middle East Precision Medicine Market Overview
  • 28.2. Middle East Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Precision Medicine Market

  • 29.1. Africa Precision Medicine Market Overview
  • 29.2. Africa Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Precision Medicine Market Competitive Landscape And Company Profiles

  • 30.1. Precision Medicine Market Competitive Landscape
  • 30.2. Precision Medicine Market Company Profiles
    • 30.2.1. Quest Diagnostics
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Roche Holding AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Medtronic plc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Novartis AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Precision Medicine Market Other Major And Innovative Companies

  • 31.1. Pfizer Inc.
  • 31.2. Qiagen
  • 31.3. AstraZeneca plc.
  • 31.4. Abbott Laboratories
  • 31.5. Nordic Bioscience A/S
  • 31.6. Takeda Pharmaceutical Company Ltd.
  • 31.7. Otsuka Pharmaceutical Co. Ltd.
  • 31.8. Daiichi Sankyo
  • 31.9. China National Pharmaceutical Group Co., Ltd.
  • 31.10. GE Healthcare
  • 31.11. Randox Laboratories
  • 31.12. Almac Group
  • 31.13. Sun Pharma
  • 31.14. Nichi-Iko Pharmaceutical Co., Ltd.
  • 31.15. Daewoong Pharmaceutical Co.,Ltd

32. Global Precision Medicine Market Competitive Benchmarking

33. Global Precision Medicine Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Precision Medicine Market

35. Precision Medicine Market Future Outlook and Potential Analysis

  • 35.1 Precision Medicine Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Precision Medicine Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Precision Medicine Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제